GlassScriptPhysician profile
Hadi S Chohan
NPI 1912164575
$79,617.36
in general payments reported to CMS, 2019-2025
51 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,826 · 2020: $1,277 · 2021: $2,831 · 2022: $13K · 2023: $10K · 2024: $19K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Food and Beverage: $6,481 · Travel and Lodging: $3,390 · Education: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,148.25 |
| Food and Beverage | $6,481.37 |
| Travel and Lodging | $3,390.08 |
| Education | $315.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $54,098.71 | 2019-2025 | Tyvaso, Remodulin, Orenitram |
| Merck Sharp & Dohme LLC | $8,847.40 | 2023-2025 | Winrevair, Keytruda |
| Genzyme Corporation | $3,026.25 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $1,996.65 | 2019-2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $1,391.71 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Philips North America LLC | $1,368.40 | 2019-2023 | |
| Pulmonx Corporation | $1,076.31 | 2022-2024 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
| Glaxosmithkline, LLC. | $876.25 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Ethicon INC. | $725.81 | 2021 | |
| Grifols USA, LLC | $484.73 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.44 | 2019-2025 | Jascayd, Stiolto Respimat, Ofev |
| Gilead Sciences, INC. | $440.46 | 2019-2023 | Veklury |
| Mallinckrodt Hospital Products INC. | $421.35 | 2021-2023 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $349.44 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $334.24 | 2019-2023 | Dupixent |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $328.34 | 2021-2025 | Glassia |
| Harmony Biosciences LLC | $328.33 | 2020-2022 | |
| Insmed, INC. | $327.32 | 2019-2025 | Arikayce |
| Sunovion Pharmaceuticals INC. | $315.94 | 2019-2020 | |
| Mylan Specialty L.P. | $245.97 | 2019-2023 | Tobi Podhaler |
| Genentech USA, INC. | $226.67 | 2019-2023 | Xolair |
| Baxter Healthcare | $194.47 | 2022-2023 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Novartis Pharmaceuticals Corporation | $184.42 | 2019-2022 | |
| Chiesi USA, INC. | $172.01 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $121.53 | 2019-2023 | Xywav |
| Abbvie INC. | $114.40 | 2020-2024 | Creon |
| Amgen INC. | $113.29 | 2022-2023 | Tezspire |
| Alcresta Therapeutics, INC. | $106.09 | 2019 | |
| Advanced Respiratory, INC | $100.71 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $89.67 | 2019-2023 | Trikafta |
| Liquidia Technologies, INC. | $80.51 | 2025 | Yutrepia |
| Nestle Healthcare Nutrition INC. | $79.01 | 2020-2022 | |
| Inspire Medical Systems, INC. | $75.74 | 2024 | Inspire |
| Electromed, INC. | $67.57 | 2021 | |
| Ge Healthcare | $62.60 | 2025 | |
| Shire North American Group INC | $59.25 | 2019 | |
| Allergan, INC. | $35.32 | 2019 | |
| Abiomed | $32.28 | 2025 | |
| Portola Pharmaceuticals, LLC | $31.13 | 2019 | |
| Paratek Pharmaceuticals, INC. | $31.08 | 2021-2022 | |
| Pfizer INC. | $30.99 | 2019 | |
| Ani Pharmaceuticals, INC. | $25.53 | 2024 | Purified Cortrophin Gel |
| Phadia US INC. | $25.25 | 2022 | |
| Vapotherm INC | $23.50 | 2023 | Vapotherm |
| Csl Behring | $16.82 | 2019 | |
| Circassia INC. | $16.13 | 2019 | |
| Vivus LLC | $15.18 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.00 | 2019 | |
| Boston Scientific Corporation | $12.88 | 2020 | |
| Mayne Pharma Commercial LLC | $11.28 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hadi Chohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.